<?xml version="1.0" encoding="UTF-8"?>
<p>Our main target herein has been the design of new potential AChE and/or BuChE inhibitors against Alzheimerâ€™s disease using 1-DNJ as the core template. Rationalisation of their biological properties by analysing interactions with key enzymatic domains is also covered herein.</p>
